Contact
Please use this form to send email to PR contact of this press release:
Moleculin Biotech, Inc. Completes NASDAQ Initial Public Offering
TO:
Please use this form to send email to PR contact of this press release:
Moleculin Biotech, Inc. Completes NASDAQ Initial Public Offering
TO: